Home Cart Sign in  
Chemical Structure| 175026-96-7 Chemical Structure| 175026-96-7
Chemical Structure| 175026-96-7

NQDI-1

CAS No.: 175026-96-7

NQDI-1 is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with IC50 of 3 μM and Ki of 500 nM.

4.5 *For Research Use Only !

Cat. No.: A165916 Purity: 98+%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg ł§Ê¶ÊÊ Inquiry Inquiry
5mg ł§ď¶ÊÊ Inquiry Inquiry
10mg łòǶÊÊ Inquiry Inquiry
25mg łîÿ¶ÊÊ Inquiry Inquiry
50mg łÇÇͶÊÊ Inquiry Inquiry
100mg łÇ§ď¶ÊÊ Inquiry Inquiry
250mg ł§Ç˶ÊÊ Inquiry Inquiry
1g łóÍ˶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    ł§Ê¶ÊÊ

  • 5mg

    ł§ď¶ÊÊ

  • 10mg

    łòǶÊÊ

  • 25mg

    łîÿ¶ÊÊ

  • 50mg

    łÇÇͶÊÊ

  • 100mg

    łÇ§ď¶ÊÊ

  • 250mg

    ł§Ç˶ÊÊ

  • 1g

    łóÍ˶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of NQDI-1

CAS No. :175026-96-7
Formula : C19H13NO4
M.W : 319.31
SMILES Code : O=C(C1=C2C3=C(NC1=O)C=CC=C3C(C4=C2C=CC=C4)=O)OCC
MDL No. :MFCD03265970
InChI Key :UFJGFNHRMPMALC-UHFFFAOYSA-N
Pubchem ID :5522952

Safety of NQDI-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of NQDI-1

MAPK

Isoform Comparison

Biological Activity

Target
  • ASK1

    ASK1, IC50:3 μM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
BV-2 cells 10 μM 24 h NQDI1 decreased the phosphorylation and expression of ASK1, reduced the phosphorylation of p-38 and JNK, decreased the activity and the expression of MMP-9, and inhibited IBA-1 expression. PMC9896749
SKOV3 cells 10 μM 24 h Inhibition of ASK1 expression, reduction of total Noxa protein and mitochondrial localization, and increase in Bcl-2 expression, thereby attenuating low glucose and metformin-induced apoptosis PMC6375187
Mouse embryonic fibroblasts (MEFs) 10 μM, 30 μM, 50 μM 24 h To determine the inhibitory effect of NQDI-1 on ASK1 phosphorylation, results showed that 10 μM NQDI-1 reduced ASK1 phosphorylation to 40% of control, 30 μM almost completely inhibited, and 50 μM completely inhibited ASK1, JNK, and p38 phosphorylation. PMC4260738

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Mice Postoperative pain model Intrathecal injection 5 μg/10 μl Once daily for 5 days NQDI-1 decreased the phosphorylation of ASK1, p-38, and JNK, reduced the activity and expression of MMP-9, and attenuated postoperative pain. PMC9896749
Nude mice Ovarian cancer xenograft model Intraperitoneal injection 1 mg/kg Once daily until tumor volume reached 150-200 mm3 To evaluate the inhibitory effect of NQDI-1 on the anti-tumor activity of metformin, it was found that NQDI-1 weakened the anti-tumor effect of metformin alone PMC6375187
Mice Ectopic ossification model Subcutaneous injection 30 μM Single injection, lasting 2 weeks To evaluate the effect of NQDI-1 on ectopic ossification, results showed that 30 μM NQDI-1 increased bone volume by 64%, comparable to the 82% increase observed in ASK1 KO mice. PMC4260738
Mice Intracerebral hemorrhage model Intracerebroventricular injection 250 nM/mouse Single dose 30 min before ICH induction NQDI-1 alone improved neurological functions and down-regulated ASK1/JNK/p38 MAPK expression after ICH. PMC6468256
Mice Liver ischemia/reperfusion injury model Intraperitoneal injection 10 mg/kg Single injection, lasting until 6 hours after reperfusion NQDI-1 alleviates liver ischemia/reperfusion injury by inhibiting the ASK1-JNK/P38 signaling pathway PMC9493190

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.13mL

0.63mL

0.31mL

15.66mL

3.13mL

1.57mL

31.32mL

6.26mL

3.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories